Chemoinformaics analysis of (z)-Non-2-en-6,8-diynoic acid isobutylamide
| Molecular Weight | 203.285 | nRot | 5 |
| Heavy Atom Molecular Weight | 186.149 | nRig | 4 |
| Exact Molecular Weight | 203.131 | nRing | 0 |
| Solubility: LogS | -2.419 | nHRing | 0 |
| Solubility: LogP | 2.555 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 34.9475 |
| nHD | 1 | BPOL | 18.4925 |
| QED | 0.535 |
| Synth | 3.332 |
| Natural Product Likeliness | 1.515 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.13 |
| CACO-2 | -3.784 |
| MDCK | 0.000131166 |
| BBB | 0.452 |
| PPB | 0.944737 |
| VDSS | 0.814 |
| FU | 0.0214713 |
| CYP1A2-inh | 0.918 |
| CYP1A2-sub | 0.174 |
| CYP2c19-inh | 0.946 |
| CYP2c19-sub | 0.526 |
| CYP2c9-inh | 0.824 |
| CYP2c9-sub | 0.95 |
| CYP2d6-inh | 0.255 |
| CYP2d6-sub | 0.638 |
| CYP3a4-inh | 0.573 |
| CYP3a4-sub | 0.17 |
| CL | 12.052 |
| T12 | 0.748 |
| hERG | 0.007 |
| Ames | 0.924 |
| ROA | 0.127 |
| SkinSen | 0.938 |
| Carcinogencity | 0.947 |
| EI | 0.917 |
| Respiratory | 0.948 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.601162 |